Praxis Precision Medicines (PRAX) Accounts Payables (2022 - 2025)
Historic Accounts Payables for Praxis Precision Medicines (PRAX) over the last 4 years, with Q3 2025 value amounting to $30.8 million.
- Praxis Precision Medicines' Accounts Payables rose 10532.31% to $30.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.8 million, marking a year-over-year increase of 10532.31%. This contributed to the annual value of $12.5 million for FY2024, which is 11544.28% up from last year.
- As of Q3 2025, Praxis Precision Medicines' Accounts Payables stood at $30.8 million, which was up 10532.31% from $28.8 million recorded in Q2 2025.
- Praxis Precision Medicines' 5-year Accounts Payables high stood at $30.8 million for Q3 2025, and its period low was $5.8 million during Q4 2023.
- Its 4-year average for Accounts Payables is $14.4 million, with a median of $12.5 million in 2024.
- Per our database at Business Quant, Praxis Precision Medicines' Accounts Payables tumbled by 6036.67% in 2023 and then soared by 25182.43% in 2025.
- Quarter analysis of 4 years shows Praxis Precision Medicines' Accounts Payables stood at $14.7 million in 2022, then crashed by 60.37% to $5.8 million in 2023, then soared by 115.44% to $12.5 million in 2024, then skyrocketed by 146.0% to $30.8 million in 2025.
- Its last three reported values are $30.8 million in Q3 2025, $28.8 million for Q2 2025, and $22.9 million during Q1 2025.